Skip to content
About
Supporter
Expert Index
Editorial Board
Editorial Team
Editorial Policy
Contact
Sign up
Visit
Home
(current)
Diseases
Parkinson's Disease
Multiple Sclerosis and Related Disorders
Headache
Amyotrophic Lateral Sclerosis
Epilepsy
Sleep Disorders
Stroke
Neuromuscular Disorders
Movement Disorders
View all Diseases
Topics
Biology
Diagnostics
Trial Updates
Treatment
Prevention
Surgery
Imaging
Genetics
COVID-19
View all Topics
Conferences
EAN 2022
ESOC 2022
AAN 2022
CONy 2022
AD/PD 2022
World Sleep 2022
View all Conferences
Features
Podcasts
About
Supporter
Expert Index
Editorial Board
Editorial Team
Editorial Policy
Contact
Sign up
Nikolaos Grigoriadis
3:30
Long-term efficacy outcomes of natalizumab vs. fingolimod in highly active RRMS
Nikolaos Grigoriadis
• 20 Sep 2021
1:28
Current and emerging therapeutics for NMOSD
Nikolaos Grigoriadis
• 20 Sep 2021
2:59
Relapses and progression in NMOSD and MS: understanding the underlying mechanisms
Nikolaos Grigoriadis
• 20 Sep 2021
3:38
Is AQP4-IgG NMOSD an exclusively relapsing disease?
Nikolaos Grigoriadis
• 20 Sep 2021
2:05
Differentiating NMOSD and MS
Nikolaos Grigoriadis
• 8 Jun 2021
1:27
BTK inhibitors gain ground in MS
Nikolaos Grigoriadis
• 8 Jun 2021
2:24
Tackling disease progression in MS
Nikolaos Grigoriadis
• 8 Jun 2021
2:27
Horizon scanning in treating disease progression in MS
Nikolaos Grigoriadis
• 8 Jun 2021